- Home
- RAPT vs ARQQ Comparison
RAPT vs ARQQ Comparison
Compare RAPT & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAPT | ARQQ |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.4M | 422.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | RAPT | ARQQ |
|---|---|---|
| Price | $35.21 | $26.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | $57.00 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 365.9K | 338.4K |
| Earning Date | 03-05-2026 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $530,000.00 |
| Revenue This Year | N/A | $1,054.72 |
| Revenue Next Year | N/A | $30.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.67 | $11.00 |
| 52 Week High | $42.39 | $62.00 |
Technical Indicators
Market Signals| Indicator | RAPT | ARQQ |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 50.41 |
| Support Level | $33.01 | $24.67 |
| Resistance Level | $35.42 | $28.15 |
| Average True Range (ATR) | 2.17 | 1.83 |
| MACD | 0.03 | 0.43 |
| Stochastic Oscillator | 83.95 | 68.46 |
Price Performance
Historical ComparisonAbout RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.